 |
REGULATORY LIAISON DEPARTMENT
The primary goal of the Regulatory Liaison Department (the "Department" or "RLD") is the development and implementation of strategic programs that support member education and enhance the quality of member services and communication with a focus on fostering and improving member knowledge and compliance with CBOE and SEC Rules and trading procedures. The programs include facilitating meetings between regulatory staff and representatives of new member organizations to discuss the "rules of the road" based on the type of business conducted by that member and making presentations and holding training seminars for members regarding key regulatory issues. The Department also develops and distributes written communications that clarify rules, policies and trading procedures and contain best practices advice, separate and apart from CBOE Regulatory Circulars. RLD staff also works to address suggestions, concerns and complaints from members regarding regulatory issues.
RLD also acts as a liaison between other Departments within the Division and is responsible for developing and implementing Division staff training and development programs.
If you would like further information about RLD, please call (312) 786-7715.
|
|
Options involve risk and are not suitable for all
investors. Prior to buying or selling an option, a person must receive a copy
of Characteristics and Risks of Standardized
Options (ODD). Copies of the ODD are available from your broker, by
calling 1-888-OPTIONS, or from The Options Clearing Corporation, One North
Wacker Drive, Suite 500, Chicago, Illinois 60606. The information on this
website is provided solely for general education and information purposes and
therefore should not be considered complete, precise, or current. Many of the
matters discussed are subject to detailed rules, regulations, and statutory
provisions which should be referred to for additional detail and are subject to
changes that may not be reflected in the website information. No statement
within the website should be construed as a recommendation to buy or sell a
security or to provide investment advice. The inclusion of non-CBOE
advertisements on the website should not be construed as an endorsement or an
indication of the value of any product, service, or website. The
Terms and Conditions govern use of this website and use of this website
will be deemed acceptance of those Terms and Conditions.
|
|